Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Expert opinion on 6-monthly luteinizing hormone-releasing hormone agonist treatment with the single-sphere depot system for prostate cancer.

× No keyword cloud information.

5 in total

1. In situ forming implants exposed to ultrasound enhance therapeutic efficacy in subcutaneous murine tumors.

Authors: Selva Jeganathan; Emily Budziszewski; Peter Bielecki; Michael C Kolios; Agata A Exner
Journal: J Control Release Date: 2020-05-07 Impact factor: 9.776

2. Patient rationale in selecting androgen deprivation (PRISAD): do we give patients what they want?

Authors: Eric Chung; Hunter Watt; Amanda Glasgow; Tim Skyring
Journal: Med Oncol Date: 2008-12-04 Impact factor: 3.064

3. Noninvasive characterization of in situ forming implants using diagnostic ultrasound.

Authors: Luis Solorio; Brett M Babin; Ravi B Patel; Justyna Mach; Nami Azar; Agata A Exner
Journal: J Control Release Date: 2010-01-11 Impact factor: 9.776

4. Pharmacokinetic and pharmacodynamic comparison of subcutaneous versus intramuscular leuprolide acetate formulations in male subjects.

Authors: Daniel Saltzstein; Neal D Shore; Judd W Moul; Franklin Chu; Raoul Concepcion; Stephan de la Motte; John A McLane; Stuart Atkinson; Alex Yang; E David Crawford
Journal: Ther Adv Urol Date: 2017-11-22

5. Subcutaneous in situ gel delivered leuprolide acetate's consistent and prolonged drug delivery maintains effective testosterone suppression independent of age and weight in men with prostate cancer.

Authors: Joseph F Renzulli; Scott T Tagawa; Stuart N Atkinson; Deborah M Boldt-Houle; Judd W Moul
Journal: BJUI Compass Date: 2020-04-22

5 in total